Genital herpes rising in England
New cases of genital herpes are increasing in England, bucking an overall fall in sexually transmitted infections…
Page 3 of Health headlines on WeSearch — deduped and updated continuously from 266+ editorial sources.

New cases of genital herpes are increasing in England, bucking an overall fall in sexually transmitted infections…
A study found that SGLT2 inhibitors significantly reduce the risk of major adverse kidney events in adults with type 2…
Recent research suggests that cannabis compounds may aid in regulating metabolism, potentially leading to weight-loss…
A phase 2 study found that a venetoclax-based regimen significantly improved survival rates in adolescents and adults…
A recent study indicates that young adults who engage in both smoking and vaping cannabis may experience increased…

Robotic-assisted mitral valve surgery has demonstrated excellent long-term repair durability and reduced hospital…

The Department of Health and Human Services is relaxing standards for electronic health records, raising concerns…

Shasta County in California successfully contained a measles outbreak by engaging trusted community members. Teachers,…

“Public health is going to have to talk about the Amish more and more”: Listen to STAT’s "First Opinion Podcast" on…

“The financial side effects of care have become clinical ones,” writes Darshak Sanghavi.

“Much of the rhetoric, imagery, and policy messaging from the Trump administration centers on extreme masculine…

Advocates were already dreading Medicaid's work requirements. New rules are worse than they feared.

While NIH-funded centers weren’t on the front lines of virus responses like the CDC or USAID, some researchers…

A survey finds that ultra-processed foods are a cross-partisan concern. And yet policy has been slow to follow.
Expert witness work offers physicians an interesting and well-compensated side gig, with many doctors finding it…
Opt-out organ donation systems in Europe are intended to simplify consent, but family discussions often complicate the…
Veligrotug, a monoclonal antibody, has shown promising results in treating moderate-to-severe thyroid eye disease. In…
A scandal at the University Hospital Zurich has led to criminal investigations linked to over 70 unexpected patient…
A recent study found that 9.1% of patients with axial spondyloarthritis (axSpA) meet the criteria for…
A study on peanut oral immunotherapy (OIT) shows promising long-term benefits for participants who began treatment at…
A study comparing conversion surgery and medication therapy for weight regain after sleeve gastrectomy found that…

Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop…

A new medical meal program in one state has shown promise in reducing healthcare costs. The initiative focuses on…

Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data…

The FDA has missed a self-imposed deadline to ban the use of electrical shock devices in people with intellectual…

“You have to understand a person's belief if you want to address it,” Deva Sharma says on the “First Opinion Podcast”…

Detailed study data for a pancreatic cancer treatment from Revolution Medicines confirmed it increased overall…

The CDC has emphasized that containing the Ebola outbreak in the Democratic Republic of Congo and Uganda is its top…

Recent advancements in pancreatic cancer treatment have been highlighted, particularly the promising results of…

The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55…

ASCO Day 3: A huge advance for pancreatic cancer, a let down for Akeso and Summit, and a new approach to immunotherapy.

A lung cancer drug developed in China was a highlight of ASCO but doctors want to see follow-up in a more diverse…

Much-awaited results at ASCO show that scientists have indeed found a way to drug a "greasy ball" involved in…

ASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.

Dr. Amitabh Ray shared a poignant experience at the ASCO 2026 annual meeting, highlighting the emotional struggles of…

Rick Pazdur on the FDA: “We've had a lot of destruction here, and it doesn't mean that we have to just go back and…

CEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.

Trump officials are disregarding the Biden administration's detailed pandemic plans in favor of their own strategy.

A recent study suggests that millions of breast cancer patients could avoid chemotherapy thanks to a new DNA test.…

KFF Health News' editor-at-large for public health discussed peptides, colorectal cancer screening, and Ebola in TV…

Donald Trump's doctor has declared him to be in excellent health following his annual medical exam. The exam took…

At the ASCO annual meeting, Bristol-Myers Squibb presented positive data regarding its treatment for multiple myeloma.…

The article discusses common misconceptions surrounding gut health and the marketing of various tests and supplements.…
The FDA has approved guselkumab for the inhibition of structural joint damage in adults with active psoriatic…
The UK government has announced a new deal allowing pharmacists in England to prescribe for more conditions without GP…
The FDA's advisory committee has recommended an updated COVID vaccine targeting the XFG variant for the 2026-2027…
The concept of bowel hygiene is gaining traction in clinical practice as a way to improve gut health. This approach…
NICE has recommended mepolizumab as an add-on treatment for adults with uncontrolled COPD and raised blood…
Experts are advising North African countries to remain vigilant regarding the Ebola outbreak in the DRC and Uganda.…

Pfizer invests billions to buy Chinese drugs, WHO maps experimental response to Ebola outbreak, and other biotech news…